Christine M Albert

Oct 28, 2024 | ahajournals.org | Christine M Albert

Get full access to this articleView all available purchase options and get full access to this article. REFERENCES1. Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N, Bertaglia E, Blomstrom Lundqvist C, Borlich M, Brandes A, et al; NOAH-AFNET 6 Investigators. Anticoagulation with edoxaban in patients with atrial high-rate episodes. N Engl J Med. 2023;389:1167–1179. doi: 10.1056/NEJMoa23030622.

May 20, 2024 | healio.com | Erik Swain |Richard Smith |Christine M Albert

Christine M. Albert, MD, MPH, FHRS, FACC The most important take-home message is that you can do a dietary intervention study in a patient population with AF. This is not an easy thing to do, and the researchers pulled it off, using a novel way of doing dietary counseling remotely. This gives us a roadmap for how we could do these trials in the future. The overall result of the trial appears to be null.

Dec 23, 2023 | beverlyhillscourier.com | Christine M Albert |Sumeet S. Chugh

You wake from a deep sleep because your heart suddenly starts racing. Your chest feels tight. Seemingly out of nowhere, your left arm begins to tingle. Could it be a passing episode? A heart attack? Or worse? Cardiac conditions—like atrial fibrillation, heart attack and sudden cardiac arrest —can leave you feeling breathless and frightened. At worst, a heart attack or an abnormal heart rhythm can lead to sudden cardiac arrest and have deadly consequences.

Nov 12, 2023 | healio.com | Erik Swain |Richard Smith |Christian T. Ruff |Christine M Albert

You've successfully added Cardiology: Arrhythmia Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: In patients with AF requiring anticoagulation, the factor XI inhibitor abelacimab greatly reduced bleeding risk compared with rivaroxaban.

Nov 12, 2023 | healio.com | Erik Swain |Richard Smith |Jeff S. Healey |Christine M Albert

You've successfully added Cardiology: Arrhythmia Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: In patients with subclinical atrial fibrillation, apixaban lowered risk for stroke and systemic embolism vs. aspirin.